249 related articles for article (PubMed ID: 31419843)
21. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma.
Liu Y; Fan L; Wang Y; Li P; Zhu J; Wang L; Zhang W; Zhang Y; Huang G
Int J Clin Exp Pathol; 2014; 7(9):5429-35. PubMed ID: 25337185
[TBL] [Abstract][Full Text] [Related]
23. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
24. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Role of CD68
Chohan MH; Perry M; Laurance-Young P; Salih VM; Foey AD
Br J Biomed Sci; 2023; 80():11065. PubMed ID: 37397243
[No Abstract] [Full Text] [Related]
26. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
27. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin's lymphoma: a systematic review and meta-analysis.
Zhang M; Gao F; Peng L; Shen L; Zhao P; Ni B; Hou J; Huang H
Cancer Cell Int; 2021 Oct; 21(1):524. PubMed ID: 34627251
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.
Mei J; Xiao Z; Guo C; Pu Q; Ma L; Liu C; Lin F; Liao H; You Z; Liu L
Oncotarget; 2016 Jun; 7(23):34217-28. PubMed ID: 27144518
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
[TBL] [Abstract][Full Text] [Related]
30. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
Allison E; Edirimanne S; Matthews J; Fuller SJ
Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
[TBL] [Abstract][Full Text] [Related]
32. Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes.
Mazur G; Haloń A; Wróbel T; Kuliczkowski K
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():73-5. PubMed ID: 15638380
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer.
Kou Y; Li Z; Sun Q; Yang S; Wang Y; Hu C; Gu H; Wang H; Xu H; Li Y; Han B
Scand J Immunol; 2022 Apr; 95(4):e13137. PubMed ID: 34964155
[TBL] [Abstract][Full Text] [Related]
34. The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Lundgren S; Karnevi E; Elebro J; Nodin B; Karlsson MCI; Eberhard J; Leandersson K; Jirström K
J Transl Med; 2017 Jul; 15(1):152. PubMed ID: 28673320
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer.
Zhao Y; Ge X; Xu X; Yu S; Wang J; Sun L
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3005-3019. PubMed ID: 31650222
[TBL] [Abstract][Full Text] [Related]
36. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
Mwafy SE; El-Guindy DM
J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.
Handl M; Hermanova M; Hotarkova S; Jarkovsky J; Mudry P; Shatokhina T; Vesela M; Sterba J; Zambo I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):54-60. PubMed ID: 29170560
[TBL] [Abstract][Full Text] [Related]
38. Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry.
Ahn JS; Al-Habib A; Vos JA; Sohani AR; Barboza-Quintana O; Flores JP; Wen S; Rosado FG
Ann Clin Lab Sci; 2020 Mar; 50(2):213-218. PubMed ID: 32366559
[TBL] [Abstract][Full Text] [Related]
39. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
40. CD163
Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
